CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population ; volume:17 ; number:1 ; day:5 ; month:9 ; year:2017 ; pages:1-5 ; date:12.2017
BMC cancer ; 17, Heft 1 (5.9.2017), 1-5, 12.2017

Keyword: Krebs
Onkologie

Creator: Hallamies, Sanna

Contributor: Pelttari, Liisa M.
Poikonen-Saksela, Paula
Jekunen, Antti
Jukkola-Vuorinen, Arja
Auvinen, Päivi
Blomqvist, Carl
Aittomäki, Kristiina
Mattson, Johanna
Nevanlinna, Heli
SpringerLink (Online service)

DOI: 10.1186/s12885-017-3631-8

URN: urn:nbn:de:1111-2017111016036

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Hallamies, Sanna
Pelttari, Liisa M.
Poikonen-Saksela, Paula
Jekunen, Antti
Jukkola-Vuorinen, Arja
Auvinen, Päivi
Blomqvist, Carl
Aittomäki, Kristiina
Mattson, Johanna
Nevanlinna, Heli
SpringerLink (Online service)

Other Objects (12)

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

BACH1 Ser919Pro variant and breast cancer risk

Comprehensive analysis of NuMAvariation in breast cancer

Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population

Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

BACH1 Ser919Pro variant and breast cancer risk

Comprehensive analysis of NuMAvariation in breast cancer

Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population

Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

BACH1 Ser919Pro variant and breast cancer risk

Comprehensive analysis of NuMAvariation in breast cancer

Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population

Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

BACH1 Ser919Pro variant and breast cancer risk

Comprehensive analysis of NuMAvariation in breast cancer

Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population

Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

BACH1 Ser919Pro variant and breast cancer risk

Comprehensive analysis of NuMAvariation in breast cancer

Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population

Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer

Screening of Finnish RAD51Cfounder mutations in prostate and colorectal cancer patients

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

BACH1 Ser919Pro variant and breast cancer risk

Comprehensive analysis of NuMAvariation in breast cancer

Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population

Breast tumors from CHEK2 1100delC- mutation carriers: genomic landscape and clinical implications

Related objects

Reset password